VCP and cardiomyopathy: Cardiac-specific overexpression of an enzymatically mutated VCP (VCPK524A) in transgenic mice resulted in an impairment of the ATPase activity within the D2 domain of VCP, and lead to the development of cardiomyopathy [78].